-
1.
公开(公告)号:US20220289785A1
公开(公告)日:2022-09-15
申请号:US17387495
申请日:2021-07-28
发明人: David TELLERS , Steven L. COLLETTI , Vadim DUDKIN , Jeffrey AARONSON , Aaron MOMOSE , Thomas Joseph TUCKER , Yu YUAN , Kathleen B. CALATI , Lu TIAN , Rubina G. PARMAR , Anthony W. SHAW , Weimin WANG , Rachel Anne STORR , Marina BUSUEK , Robert A. KOWTONIUK
IPC分类号: C07H15/26 , A61K31/7056 , A61K31/713 , A61K47/54 , C12N15/113
摘要: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
-
2.
公开(公告)号:US20180079769A1
公开(公告)日:2018-03-22
申请号:US15807143
申请日:2017-11-08
发明人: David TELLERS , Steven L. COLLETTI , Vadim DUDKIN , Jeffrey AARONSON , Aaron MOMOSE , Thomas Joseph TUCKER , Yu YUAN , Kathleen B. CALATI , Lu TIAN , Rubina G. PARMAR , Anthony W. SHAW , Weimin WANG , Rachel Anne STORR , Marina BUSUEK , Robert A. KOWTONIUK
IPC分类号: C07H15/26
CPC分类号: C07H15/26 , A61K31/7056 , A61K31/713 , A61K47/549 , C12N15/113 , C12N2310/17 , C12N2310/3513 , A61K2300/00
摘要: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
-
3.
公开(公告)号:US20170306324A1
公开(公告)日:2017-10-26
申请号:US15481942
申请日:2017-04-07
发明人: David TELLERS , Steven L. COLLETTI , Vadim DUDKIN , Jeffrey AARONSON , Aaron MOMOSE , Thomas Joseph TUCKER , Yu YUAN , Kathleen B. CALATI , Lu TIAN , Rubina G. PARMAR , Anthony W. SHAW , Weimin WANG , Rachel Anne STORR , Marina BUSUEK , Robert A. KOWTONIUK
IPC分类号: C12N15/113 , A61K31/7056 , C07H15/26 , A61K31/713
CPC分类号: C07H15/26 , A61K31/7056 , A61K31/713 , A61K47/549 , C12N15/113 , C12N2310/17 , C12N2310/3513 , A61K2300/00
摘要: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
-
4.
公开(公告)号:US20190153016A1
公开(公告)日:2019-05-23
申请号:US16268262
申请日:2019-02-05
发明人: David TELLERS , Steven L. COLLETTI , Vadim DUDKIN , Jeffrey AARONSON , Aaron MOMOSE , Thomas Joseph TUCKER , Yu YUAN , Kathleen B. CALATI , Lu TIAN , Rubina G. PARMAR , Anthony W. SHAW , Weimin WANG , Rachel Anne STORR , Marina BUSUEK , Robert A. KOWTONIUK
IPC分类号: C07H15/26 , C12N15/113 , A61K31/713 , A61K47/54 , A61K31/7056
摘要: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
-
公开(公告)号:US20170233731A1
公开(公告)日:2017-08-17
申请号:US15363490
申请日:2016-11-29
发明人: David TELLERS , Steven COLLETTI , Vadim DUDKIN , Norihiro IKEMOTO , Hongbiao LIAO , Craig PARISH , Tao PEI , Anthony SHAW , Quang TRUONG , Lijun WANG , Yu YUAN , Man ZHU
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , A61K47/549 , C07H15/26 , C12N2310/11 , C12N2310/14 , C12N2310/351
摘要: Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
-
-
-
-